Advertisement
Screener

ACCELERON PHARMA INC. Net Income

ACCELERON PHARMA INC. Net Income

ACCELERON PHARMA INC. reported Net Income of -$70.47 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.

Discontinued › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2021-11-04

  • ACCELERON PHARMA INC. net income (loss) attributable to parent for the quarter ending 2021-09-30 was -$70.47M.
  • ACCELERON PHARMA INC. net income (loss) attributable to parent for the quarter ending 2021-06-30 was -$63.52M.
  • ACCELERON PHARMA INC. net income (loss) attributable to parent for the quarter ending 2021-03-31 was -$63.47M.
  • ACCELERON PHARMA INC. net income (loss) attributable to parent for the quarter ending 2020-12-31 was -$57.40M.
  • ACCELERON PHARMA INC. net income (loss) attributable to parent for fiscal 2020 was -$166.03M.
  • ACCELERON PHARMA INC. net income (loss) attributable to parent for fiscal 2019 was -$124.86M.
  • ACCELERON PHARMA INC. net income (loss) attributable to parent for fiscal 2018 was -$118.87M.
  • ACCELERON PHARMA INC. net income (loss) attributable to parent for fiscal 2017 was -$108.45M.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 3 month as first filedNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 12 month
2021-09-30-$70.47M
10-Q · filed 2021-11-04
-$133.99M
derived: sum of 2 quarters · filed 2021-11-04
-$197.46M
10-Q · filed 2021-11-04
-$254.85M
derived: sum of 4 quarters · filed 2021-11-04
2021-06-30-$63.52M
10-Q · filed 2021-11-04
-$126.99M
10-Q · filed 2021-08-05
-$184.39M
derived: sum of 3 quarters · filed 2021-11-04
-$223.63M
derived: sum of 4 quarters · filed 2021-11-04
2021-03-31-$63.47M
10-Q · filed 2021-11-04
-$120.87M
derived: sum of 2 quarters · filed 2021-11-04
-$160.11M
derived: sum of 3 quarters · filed 2021-11-04
-$178.56M
derived: sum of 4 quarters · filed 2021-11-04
2020-12-31-$57.40M
10-K · filed 2021-02-25
-$96.64M
derived: sum of 2 quarters · filed 2021-11-04
-$115.09M
derived: sum of 3 quarters · filed 2021-11-04
-$166.03M
10-K · filed 2021-02-25
2020-09-30-$39.24M
10-Q · filed 2021-11-04
-$57.70M
derived: sum of 2 quarters · filed 2021-11-04
-$108.64M
10-Q · filed 2021-11-04
-$132.21M
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30-$18.45M
10-Q · filed 2021-11-04
-$69.39M
10-Q · filed 2021-08-05
-$92.97M
derived: sum of 3 quarters · filed 2021-11-04
-$138.33M
derived: sum of 4 quarters · filed 2021-11-04
2020-03-31-$50.94M
10-Q · filed 2021-11-04
-$74.51M
derived: sum of 2 quarters · filed 2021-11-04
-$119.88M
derived: sum of 3 quarters · filed 2021-11-04
-$137.75M
derived: sum of 4 quarters · filed 2021-11-04
2019-12-31-$23.57M
10-K · filed 2021-02-25
-$68.94M
derived: sum of 2 quarters · filed 2021-02-25
-$86.81M
derived: sum of 3 quarters · filed 2021-02-25
-$124.86M
10-K · filed 2021-02-25
2019-09-30-$45.37M
10-K · filed 2021-02-25
-$63.23M
derived: sum of 2 quarters · filed 2021-02-25
-$101.28M
10-Q · filed 2020-11-05
-$136.02M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$17.86M
10-K · filed 2021-02-25
-$55.91M
10-Q · filed 2020-08-06
-$90.65M
derived: sum of 3 quarters · filed 2021-02-25
-$119.63M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$38.05M
10-K · filed 2021-02-25
-$72.79M
derived: sum of 2 quarters · filed 2021-02-25
-$101.77M
derived: sum of 3 quarters · filed 2021-02-25
-$130.70M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$34.73M
10-K · filed 2020-02-27
-$63.71M
derived: sum of 2 quarters · filed 2020-02-27
-$92.65M
derived: sum of 3 quarters · filed 2020-02-27
-$118.87M
10-K · filed 2021-02-25
2018-09-30-$28.98M
10-K · filed 2020-02-27
-$57.92M
derived: sum of 2 quarters · filed 2020-02-27
-$84.14M
10-Q · filed 2019-11-06
-$112.06M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30-$28.94M
10-K · filed 2020-02-27
-$55.16M
10-Q · filed 2019-08-05
-$83.08M
derived: sum of 3 quarters · filed 2020-02-27
-$108.53M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31-$26.22M
10-K · filed 2020-02-27
-$54.15M
derived: sum of 2 quarters · filed 2020-02-27
-$79.60M
derived: sum of 3 quarters · filed 2020-02-27
-$109.27M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31-$27.93M
10-K · filed 2019-02-27
-$53.38M
derived: sum of 2 quarters · filed 2019-02-27
-$83.05M
derived: sum of 3 quarters · filed 2019-02-27
-$108.45M
10-K · filed 2020-02-27
2017-09-30-$25.45M
10-K · filed 2019-02-27
-$55.12M
derived: sum of 2 quarters · filed 2019-02-27
-$80.53M
10-Q · filed 2018-10-30
-$99.81M
derived: sum of 4 quarters · filed 2019-02-27
2017-06-30-$29.67M
10-K · filed 2019-02-27
-$55.08M
10-Q · filed 2018-08-02
-$74.36M
derived: sum of 3 quarters · filed 2019-02-27
-$95.13M
derived: sum of 4 quarters · filed 2019-02-27
2017-03-31-$25.41M
10-K · filed 2019-02-27
-$44.70M
derived: sum of 2 quarters · filed 2019-02-27
-$65.47M
derived: sum of 3 quarters · filed 2019-02-27
-$87.48M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31-$19.29M
10-K · filed 2018-02-27
-$40.06M
derived: sum of 2 quarters · filed 2018-02-27
-$62.07M
derived: sum of 3 quarters · filed 2018-02-27
-$57.01M
10-K · filed 2019-02-27
2016-09-30-$20.77M
10-K · filed 2018-02-27
-$42.79M
derived: sum of 2 quarters · filed 2018-02-27
-$37.73M
10-Q · filed 2017-11-07
-$64.81M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30-$22.02M
10-K · filed 2018-02-27
-$16.96M
10-Q · filed 2017-08-03
-$44.04M
derived: sum of 3 quarters · filed 2018-02-27
-$55.90M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$5.06M
10-K · filed 2018-02-27
-$22.02M
derived: sum of 2 quarters · filed 2018-02-27
-$33.88M
derived: sum of 3 quarters · filed 2018-02-27
-$44.26M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31-$27.08M
10-K · filed 2017-03-01
-$38.94M
derived: sum of 2 quarters · filed 2017-03-01
-$49.32M
derived: sum of 3 quarters · filed 2017-03-01
-$63.89M
10-K · filed 2018-02-27
2015-09-30-$11.86M
10-K · filed 2017-03-01
-$22.24M
derived: sum of 2 quarters · filed 2017-03-01
-$36.81M
10-Q · filed 2016-11-03
-$54.43M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30-$10.38M
10-K · filed 2017-03-01
-$24.95M
10-Q · filed 2016-08-04
-$42.57M
derived: sum of 3 quarters · filed 2017-03-01
-$50.55M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31-$14.57M
10-K · filed 2017-03-01
-$32.19M
derived: sum of 2 quarters · filed 2017-03-01
-$40.16M
derived: sum of 3 quarters · filed 2017-03-01
-$56.71M
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31-$17.62M
10-K · filed 2016-02-25
-$25.59M
derived: sum of 2 quarters · filed 2016-02-25
-$42.14M
derived: sum of 3 quarters · filed 2016-02-25
-$51.26M
10-K · filed 2017-03-01
2014-09-30-$7.97M
10-K · filed 2016-02-25
-$24.52M
derived: sum of 2 quarters · filed 2016-02-25
-$33.64M
10-Q · filed 2015-11-04
-$51.75M
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30-$16.55M
10-K · filed 2016-02-25
-$25.67M
10-Q · filed 2015-08-06
-$43.78M
derived: sum of 3 quarters · filed 2016-02-25
-$62.29M
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31-$9.12M
10-K · filed 2016-02-25
-$27.23M
derived: sum of 2 quarters · filed 2016-02-25
-$45.74M
derived: sum of 3 quarters · filed 2016-02-25
-$32.66M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31-$18.11M
10-K · filed 2015-03-02
-$36.62M
derived: sum of 2 quarters · filed 2015-03-02
-$23.55M
derived: sum of 3 quarters · filed 2015-03-02
-$21.90M
10-K · filed 2016-02-25
2013-09-30-$18.51M
10-K · filed 2015-03-02
-$24.79M
10-Q · filed 2013-11-14
-$5.43M
derived: sum of 2 quarters · filed 2015-03-02
-$20.89M
10-Q · filed 2013-11-14
-$14.17M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$13.08M
10-K · filed 2015-03-02
$14.72M
derived: sum of 2 quarters · filed 2015-03-02
$4.35M
derived: sum of 3 quarters · filed 2015-03-02
-$2.87M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$1.65M
10-K · filed 2015-03-02
-$8.73M
derived: sum of 2 quarters · filed 2015-03-02
-$15.95M
derived: sum of 3 quarters · filed 2015-03-02
-$23.35M
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31-$10.38M
10-K · filed 2014-03-17
-$17.59M
derived: sum of 2 quarters · filed 2014-03-17
-$24.99M
derived: sum of 3 quarters · filed 2014-03-17
-$32.58M
10-K · filed 2015-03-02
2012-09-30-$7.21M
10-K · filed 2014-03-17
-$13.96M
10-Q · filed 2013-11-14
-$14.62M
derived: sum of 2 quarters · filed 2014-03-17
-$42.50M
10-Q · filed 2013-11-14
2012-06-30-$7.40M
10-K · filed 2014-03-17
-$14.99M
derived: sum of 2 quarters · filed 2014-03-17
2012-03-31-$7.59M
10-K · filed 2014-03-17
2011-12-31$36.27M
10-K · filed 2014-03-17